Tissue factor is the receptor for plasminogen type 1 on 1-LN human prostate cancer cells

被引:24
作者
Gonzalez-Gronow, M [1 ]
Gawdi, G [1 ]
Pizzo, SV [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA
关键词
D O I
10.1182/blood.V99.12.4562
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tissue factor (TF), the initiator of the extrinsic pathway of coagulation, binds plasminogen (Pg) with high affinity through an interaction between kringles 1-3 of Pg and the extracellular domain of TF. We investigated the binding of Pg type 1 (Pg 1) and Pg type 2 (Pg 2) to highly invasive, TF-expressing, 1-LN human prostate tumor cells and to TF Isolated from 1-LN cell membranes. Pg 1, containing both N-linked and O-linked oligosaccharide chains, bound to isolated TF with high affinity, whereas Pg 2, containing only one O-linked oligosaccharide chain, did not bind to TF. Although Pg 1 and Pg 2 bind to 1-LN cells, only anti-TF antibodies inhibited the binding of Pg 1, suggesting that TF functions as the receptor for Pg 1 on 1-LN cells. Binding of Pg 1 to isolated TF was inhibited by 6-aminohexanoic acid and alpha-methylmannoside, suggesting that Pg 1 L-lysine binding sites and the biantennary, mannose-containing N-linked oligosaccharide chain are involved in this interaction. Binding of Pg 1 to 1-LN cells promoted activation by receptor-bound urinary-type Pg activator (u-PA) and initiated a Ca++ signaling cascade. In previous studies we demonstrated that the Pg 2 O-linked carbohydrate chain is -essential for its binding to CD26 on 1-LN cells. The current studies suggest that Pg oligosaccharide chains regulate the binding of Pg 1 and Pg 2 to separate receptors on the cell surface. (C) 2002 by The American Society of Hematology.
引用
收藏
页码:4562 / 4567
页数:6
相关论文
共 37 条
[1]   Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor [J].
Abe, K ;
Shoji, M ;
Chen, J ;
Bierhaus, A ;
Danave, I ;
Micko, C ;
Casper, K ;
Dillehay, DL ;
Nawroth, PP ;
Rickles, FR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (15) :8663-8668
[2]  
ALBINI A, 1987, CANCER RES, V47, P3239
[3]  
Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO
[4]  
2-Z
[5]  
BACH R, 1981, J BIOL CHEM, V256, P8324
[6]  
BROCKWAY WJ, 1972, ARCH BIOCHEM BIOPHYS, V151, P191
[7]   TISSUE FACTOR PROMOTES MELANOMA METASTASIS BY A PATHWAY INDEPENDENT OF BLOOD-COAGULATION [J].
BROMBERG, ME ;
KONIGSBERG, WH ;
MADISON, JF ;
PAWASHE, A ;
GAREN, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (18) :8205-8209
[8]   Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases [J].
Cao, YH ;
O'Reilly, MS ;
Marshall, B ;
Flynn, E ;
Ji, RW ;
Folkman, J .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (05) :1055-1063
[9]   The plasminogen activation system in tumour invasion and metastasis [J].
deVries, TJ ;
vanMuijen, GNP ;
Ruiter, DJ .
PATHOLOGY RESEARCH AND PRACTICE, 1996, 192 (07) :718-733
[10]   Tissue factor regulates plasminogen binding and activation [J].
Fan, ZQ ;
Larson, PJ ;
Bognacki, J ;
Raghunath, PN ;
Tomaszewski, JE ;
Kuo, A ;
Canziani, G ;
Chaiken, I ;
Cines, DB ;
Higazi, AAR .
BLOOD, 1998, 91 (06) :1987-1998